- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 09:51 | Resources Top 5: Trek steps up its gold exploration pace at Christmas Creek | ||
| 08:50 | Closing Bell: Banks lead ASX recovery as CPI softens to 2021 levels | ||
| 06:50 | The four traits of successful investors | ||
| 05:50 | Lunch Wrap: ASX loses fizz as soft CPI lifts banks; DroneShield soars on record deal | ||
| 05:50 | The 15 highest paying tech jobs right now | ||
| 04:50 | Health Check: UBS turns ultra-bullish on Aussie healthcare leaders | ||
| 04:50 | Break it Down: Astral unveils golden opportunity with Mandilla PFS | ||
| 03:50 | Top 10 at 11: Cautious open to ASX trading as Ovanti targets US expansion | ||
| Di | Rise and Shine: Everything you need to know before the ASX opens | ||
| Di | Broker Upgrades: WA gold developer becomes Canaccord's latest 'spec buy' | ||
| Di | Biocurious: CSL's R&D chief says drug development is like falling in love | ||
| Di | IPO Watch: Missing LinQ in Macquarie Arc's gold chain to float on ASX | ||
| Di | Dengue surges as climate change bites but one Aussie drug trial has slapped symptoms | ||
| Di | Santos and bidder Abu Dhabi National Oil Company are two giants in their regions | ||
| Di | Closing Bell: ASX surges as missiles fly ahead of Iran-Israel ceasefire | ||
| Di | Resources Top 5: Olympio Metals surges out of starting blocks with gold observed in first hole | ||
| Di | AI is killing Google search: is your business next? | ||
| Di | Lunch Wrap: Virgin's ASX comeback lifts market mood as oil stocks slump | ||
| Di | Health Check: Inoviq cops ASX 'speeding ticket' query over cancer study headline claims | ||
| Di | Top 10 at 11: ASX surges as Iran-Israel conflict fizzles out; GBM Resources leads early gainers | ||
| Di | The 9 lowest home loan rates you can get right now | ||
| Mo | Thanks a Million: These five ASX gold hopefuls are closing in on the 1Moz milestone | ||
| Mo | US-Iran crisis reveals US dollar's waning safe haven status | ||
| Mo | Clock ticking on Sweden's uranium ban as Europe bets on the power of the atom | ||
| Mo | Dr Boreham's Crucible: Can Sofdra become the 'world's most successful dermatology drug?' |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .